BioLargo, Inc. Stock price

Equities

BLGO

US09065A1007

Commodity Chemicals

Market Closed - OTC Markets 03:51:33 2024-03-27 pm EDT 5-day change 1st Jan Change
0.3394 USD +0.80% Intraday chart for BioLargo, Inc. -4.15% +102.02%
Sales 2023 * 11.71M Sales 2024 * 18.52M Capitalization 99.49M
Net income 2023 * -4M Net income 2024 * -1M EV / Sales 2023 * 8.5 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 5.37 x
P/E ratio 2023 *
-17 x
P/E ratio 2024 *
-
Employees 33
Yield 2023 *
-
Yield 2024 *
-
Free-Float 85.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.80%
1 week-4.15%
Current month-13.31%
1 month-6.09%
3 months+98.71%
6 months+99.65%
Current year+102.02%
More quotes
1 week
0.33
Extreme 0.3271
0.37
1 month
0.31
Extreme 0.305
0.45
Current year
0.16
Extreme 0.1635
0.45
1 year
0.15
Extreme 0.15
0.45
3 years
0.15
Extreme 0.15
0.45
5 years
0.10
Extreme 0.1
0.45
10 years
0.10
Extreme 0.1
1.24
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 02-05-31
Director of Finance/CFO 68 08-01-31
Chief Operating Officer 55 02-05-31
Members of the board TitleAgeSince
Director/Board Member 81 06-04-27
Chief Tech/Sci/R&D Officer 77 07-03-31
Chief Executive Officer 61 02-05-31
More insiders
Date Price Change Volume
24-03-27 0.3394 +0.80% 328,005
24-03-26 0.3367 -2.25% 257,744
24-03-25 0.3445 +1.34% 781,787
24-03-22 0.34 -5.58% 446,249
24-03-21 0.36 +1.67% 352,299

Delayed Quote OTC Markets, March 27, 2024 at 03:51 pm EDT

More quotes
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. Its segments include ONM Environmental, which sells odor and volatile organic control products and services in Westminster, California; Clyra Medical Technologies (Clyra Medical), which develops and sells medical products based on its technologies; BLEST, which provides professional engineering services on a time and materials basis for outside clients; BioLargo Water (Water), which focuses on commercializing the Advanced Oxidation System (AOS) technology, and BioLargo Energy Technologies, Inc. (BETI), which commercializes sodium-sulfur battery technology.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3394 USD
Average target price
0.35 USD
Spread / Average Target
+3.12%
Consensus
  1. Stock
  2. Equities
  3. Stock BioLargo, Inc. - OTC Markets